202 related articles for article (PubMed ID: 34563196)
1. An in vivo pharmacokinetic study of metformin microparticles as an oral sustained release formulation in rabbits.
Bouriche S; Alonso-García A; Cárceles-Rodríguez CM; Rezgui F; Fernández-Varón E
BMC Vet Res; 2021 Sep; 17(1):315. PubMed ID: 34563196
[TBL] [Abstract][Full Text] [Related]
2. Expert Design and Optimization of Ethyl Cellulose-Poly (ε-caprolactone) Blend Microparticles For Gastro-Retentive Floating Delivery of Metformin Hydrochloride.
Salatin S; Jelvehgari M
Curr Drug Deliv; 2021; 18(8):1125-1135. PubMed ID: 33563167
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
Hu LD; Liu Y; Tang X; Zhang Q
Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
[TBL] [Abstract][Full Text] [Related]
4. Gastroretentive behavior of orally administered radiolabeled tamarind seed formulations in rabbits validated by gamma scintigraphy.
Razavi M; Karimian H; Yeong CH; Fadaeinasab M; Khaing SL; Chung LY; Mohamad Haron DE; Noordin MI
Drug Des Devel Ther; 2017; 11():1-15. PubMed ID: 28031701
[TBL] [Abstract][Full Text] [Related]
5. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
[TBL] [Abstract][Full Text] [Related]
6. Steady-state pharmacokinetics of a novel extended-release metformin formulation.
Timmins P; Donahue S; Meeker J; Marathe P
Clin Pharmacokinet; 2005; 44(7):721-9. PubMed ID: 15966755
[TBL] [Abstract][Full Text] [Related]
7. Formulation, physicochemical characterization and in-vivo evaluation of ion-sensitive metformin loaded-biopolymeric beads.
Allam AN; Mehanna MM
Drug Dev Ind Pharm; 2016; 42(3):497-505. PubMed ID: 26114554
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic profile of chitosan modified poly lactic co-glycolic acid biodegradable nanoparticles following oral delivery of gentamicin in rabbits.
Akhtar B; Muhammad F; Aslam B; Saleemi MK; Sharif A
Int J Biol Macromol; 2020 Dec; 164():1493-1500. PubMed ID: 32735923
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro characteristics for insulin-loaded PLA microparticles prepared by w/o/w solvent evaporation method with electrolytes in the continuous phase.
Yeh MK; Chen JL; Chiang CH
J Microencapsul; 2004 Nov; 21(7):719-28. PubMed ID: 15799222
[TBL] [Abstract][Full Text] [Related]
10. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet.
Qin C; He W; Zhu C; Wu M; Jin Z; Zhang Q; Wang G; Yin L
Int J Pharm; 2014 May; 466(1-2):276-85. PubMed ID: 24607209
[TBL] [Abstract][Full Text] [Related]
11. Comparative Bioavailability of Metformin Hydrochloride Oral Solution Versus Metformin Hydrochloride Tablets in Fasting Mexican Healthy Volunteers.
Garza-Ocañas L; González-Canudas J; Tamez-de la O E; Badillo-Castañeda C; Gómez-Meza MV; Romero-Antonio Y; Molina-Pérez A; Amador-Hernández AG
Adv Ther; 2019 Feb; 36(2):407-415. PubMed ID: 30565181
[TBL] [Abstract][Full Text] [Related]
12. Selection of PLA polymers for the development of injectable prilocaine controlled release microparticles: usefulness of thermal analysis.
Bragagni M; Beneitez C; Martín C; Hernán Pérez de la Ossa D; Mura PA; Gil-Alegre ME
Int J Pharm; 2013 Jan; 441(1-2):468-75. PubMed ID: 23164705
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic evaluation of floating microspheres of metformin hydrochloride.
Pandit V; Pai RS; Yadav V; Devi K; Surekha BB; Inamdar MN; Suresh S
Drug Dev Ind Pharm; 2013 Jan; 39(1):117-27. PubMed ID: 22372865
[TBL] [Abstract][Full Text] [Related]
14. Development and pharmacokinetic evaluation of alginate-pectin polymeric rafts forming tablets using box behnken design.
Abbas G; Hanif M
Drug Dev Ind Pharm; 2018 Dec; 44(12):2026-2037. PubMed ID: 30084289
[TBL] [Abstract][Full Text] [Related]
15. Influence of polymer blends on the characterization of gliclazide--encapsulated into poly (ε-caprolactone) microparticles.
Barakat NS; Shazly GA; Almedany AH
Drug Dev Ind Pharm; 2013 Feb; 39(2):352-62. PubMed ID: 22540378
[TBL] [Abstract][Full Text] [Related]
16. Preparation of an oil suspension containing ondansetron hydrochloride as a sustained release parenteral formulation.
Nguyen TT; Duong VA; Maeng HJ; Chi SC
Drug Deliv Transl Res; 2020 Feb; 10(1):282-295. PubMed ID: 31659599
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
[TBL] [Abstract][Full Text] [Related]
18. Ivermectin-loaded microparticles for parenteral sustained release: in vitro characterization and effect of some formulation variables.
Camargo JA; Sapin A; Daloz D; Maincent P
J Microencapsul; 2010; 27(7):609-17. PubMed ID: 20695833
[TBL] [Abstract][Full Text] [Related]
19. Design and in vitro and in vivo characterization of mucoadhesive matrix pellets of metformin hydrochloride for oral controlled release: a technical note.
Ige PP; Gattani SG
Arch Pharm Res; 2012 Mar; 35(3):487-98. PubMed ID: 22477196
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets.
Ghim JL; Phuong NTT; Kim MJ; Kim EJ; Song GS; Ahn S; Shin JG; Kim EY
Drug Des Devel Ther; 2019; 13():1623-1632. PubMed ID: 31190741
[No Abstract] [Full Text] [Related]
[Next] [New Search]
